Related Experiment Video
Updated: Dec 16, 2025

Quantitative Real-Time PCR Evaluation of microRNA Expressions in Mouse Kidney with Unilateral Ureteral Obstruction
Published on: August 27, 2020
A novel urinary biomarker protein panel to identify children with ureteropelvic junction obstruction - A pilot study
Charan Kumar V Devarakonda1, Emily R Shearier1, Chaoran Hu2
1Center for Vascular Biology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT, 06030, USA.
Insights
New urinary biomarker proteins were identified to reliably detect ureteropelvic junction obstruction (UPJO) in children. This panel of proteins offers a promising tool for diagnosing obstructive uropathy in infants.
Area of Science:
- Biochemistry
- Pediatric Nephrology
- Biomarker Discovery
Background:
- Ureteropelvic junction obstruction (UPJO) diagnosis in children lacks consistent urinary biomarkers.
- Existing protein biomarkers show variable predictive accuracy, necessitating improved diagnostic tools.
Purpose of the Study:
- To identify and validate a panel of reliable urinary biomarker proteins for diagnosing UPJO in pediatric patients.
- To establish a consistent and accurate method for detecting obstructive uropathy in infants.
Main Methods:
- Mass spectrometry analysis of urine from infants with and without UPJO.
- Proteins preferentially identified in UPJO samples were selected and ranked by diagnostic odds ratio.
- Top candidate proteins were validated using ELISA, with results normalized to urine creatinine.
Main Results:
- Five proteins (prostaglandin-reductase-1, ficolin-2, nicotinate-nucleotide pyrophosphorylase, immunoglobulin superfamily-containing leucine-rich-repeat-protein, vascular cell adhesion molecule-1) were identified at higher levels in UPJO samples.
- The fold-change of median protein concentrations ranged from 2.9 to 9.4.
- A prevalence order of PTGR1>FCN2>QPRT>ISLR>VCAM1 was observed in UPJO samples.
Conclusions:
- A novel panel of urinary proteins can reliably distinguish between obstructed and non-obstructed infants.
- This biomarker panel holds potential for diagnosing obstructive uropathy and may be applicable to other diseases.
Introduction And Objective:
Reliable urinary biomarker proteins would be invaluable in identifying children with ureteropelvic junction obstruction (UPJO) as the existing biomarker proteins are inconsistent in their predictive ability. Therefore, the aim of this study was to identify consistent and reliable urinary biomarker proteins in children with UPJO.
Methods:
To identify candidate biomarker proteins, total protein from age-restricted (<2 years) and sex-matched (males) control (n = 22) and UPJO (n = 21) urine samples was analyzed by mass spectrometry. Proteins that were preferentially identified in UPJO samples were selected (2-step process) and ranked according to their diagnostic odds ratio value. The top ten proteins with highest odds ratio values were selected and tested individually by ELISA. The total amount of each protein was normalized to urine creatinine and the median with interquartile ranges for control and UPJO samples was determined. Additionally, fold change (UPJO/Control) of medians of the final panel of 5 proteins was also determined. Finally, we calculated the average + 3(SD) and average + 4(SD) values of each of the 5 proteins in the control samples and used it as an arbitrary cutoff to classify individual control and UPJO samples.
Results:
In the first step of our selection process, we identified 171 proteins in UPJO samples that were not detected in the majority of the control samples (16/22 samples, or 72.7%). Of the 171 proteins, only 50 proteins were detected in at least 11/21 (52.4%) of the UPJO samples and hence were selected in the second step. Subsequently, these 50 proteins were ranked according to the odds ratio value and the top 10 ranked proteins were validated by ELISA. Five of the 10 proteins - prostaglandin-reductase-1, ficolin-2, nicotinate-nucleotide pyrophosphorylase [carboxylating], immunoglobulin superfamily-containing leucine-rich-repeat-protein and vascular cell adhesion molecule-1 were present at higher levels in the UPJO samples (fold-change of the median protein concentrations ranging from 2.9 to 9.4) and emerged as a panel of biomarkers to identify obstructive uropathy. Finally, the order of prevalence of the 5 proteins in UPJO samples is PTGR1>FCN2>QPRT>ISLR>VCAM1.
Conclusion:
In summary, this unique screening strategy led to the identification of previously unknown biomarker proteins that when screened collectively, may reliably distinguish between obstructed vs. non-obstructed infants and may prove useful in identifying informative biomarker panels for biological samples from many diseases.
Related Concept Videos
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Urodynamic Studies: Uroflowmetry
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Ureters
Imaging Studies VI: Voiding Cystourethrography and Cystography
Acute Kidney Injury IV: Diagnostic Studies and Prevention

